Yoon Woong-sup is the CEO and Vice Chairman of Ildong Pharmaceutical.
We are working on developing various new drugs, including COVID-19 treatments, with the goal of achieving annual sales of 1 trillion won and operating profit of 100 billion won.
As profitability has deteriorated due to increased research and development costs, cost reductions, including the reduction of executives, are being pursued.
Born on July 7, 1967 in Seoul. He is the grandson of Ildong Pharmaceutical founder Yoon Yong-gu and the eldest son of Ildong Pharmaceutical Chairman Yoon Won-young.
He graduated from Yeongdong High School and Yonsei University's Department of Applied Statistics and received a master's degree in accounting from Georgia State University in US.
He worked as an accountant at KPMG International before joining Ildong Pharmaceuticals as a managing director.
After serving as PI team leader, planning and coordination director, executive director, and vice president, he stood on the front line of management as each representative of Ildong Pharmaceutical.
After Ildong Pharmaceutical converted into a holding company, Ildong Holdings, he took on the role of CEO of Ildong Pharmaceutical, a business company, and is in full swing of third-generation management.
He values 'execution' and believes that execution becomes stronger when the direction and goal are clear.
Similar to founder Yoon Yong-gu, his personality is gentle and he actively accepts opinions from practitioners.